1. Advances in the development of histone lysine demethylase inhibitors. (August 2015) Authors: Maes, Tamara; Carceller, Elena; Salas, Jordi; Ortega, Alberto; Buesa, Carlos Journal: Current opinion in pharmacology Issue: Volume 23(2015) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease. (June 2015) Authors: Maes, Tamara; Mascaró, Cristina; Ortega, Alberto; Lunardi, Serena; Ciceri, Filippo; P Somervaille, Tim C; Buesa, Carlos Journal: Epigenomics Issue: Volume 7:Number 4(2015) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease. (June 2015) Authors: Maes, Tamara; Mascaró, Cristina; Ortega, Alberto; Lunardi, Serena; Ciceri, Filippo; P Somervaille, Tim C; Buesa, Carlos Journal: Epigenomics Issue: Volume 7:Number 4(2015) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease. (June 2015) Authors: Maes, Tamara; Mascaró, Cristina; Ortega, Alberto; Lunardi, Serena; Ciceri, Filippo; P Somervaille, Tim C; Buesa, Carlos Journal: Epigenomics Issue: Volume 7:Number 4(2015) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease. (June 2015) Authors: Maes, Tamara; Mascaró, Cristina; Ortega, Alberto; Lunardi, Serena; Ciceri, Filippo; Somervaille, Tim C P; Buesa, Carlos Journal: Epigenomics Issue: Volume 7:Number 4(2015) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P2‐005: SAFETY EVALUATION OF VAFIDEMSTAT ON MILD TO MODERATE ALZHEIMER'S SUBJECTS. (1st July 2019) Authors: Bullock, Roger Alan; Xaus, Jordi; Gutierrez, Sonia; Buesa, Carlos; Maes, Tamara Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 11 Page Start: P572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P4‐316: The dual lsd1/maob inhibitor ory2001 prevents the development of the memory deficit in samp8 mice through induction of neuronal plasticity and reduction of neuroinflammation. (1st July 2015) Authors: Buesa, Carlos; Mascaró, Cristina; Rotllant, David; Griñan-Ferré, Christian; Pallàs, Mercè; Maes, Tamara Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 19 Page Start: P905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P4‐404: Ory‐2001: An Epigenetic Drug for the Treatment of Cognition Defects in Alzheimer'S Disease and Other Neurodegenerative Disorders. (1st July 2016) Authors: Maes, Tamara; Mascaró, Cristina; Rotllant, David; Cavalcanti, Fernando; Carceller, Elena; Ortega, Alberto; Molinero, Cesar; Buesa, Carlos Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2014)Part 24 Page Start: P1192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Vafidemstat in mild to moderate Alzheimer's disease: The ETHERAL study European cohort interim analysis: Update on pharmacologic and nonpharmacologic interventions. (7th December 2020) Authors: Bullock, Roger Alan; Ropacki, Michael T.; Gutierrez, Sonia; Xaus, Jordi; Maes, Tamara; Buesa, Carlos Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 6 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗